WebbVaxxass is a biotechnology company focused on needle-free vaccination technology. Brisbane, Queensland, Australia 51-100 Series C Private www.vaxxas.com 58,048 … WebbWe’re incredibly proud and humbled to share #Vaxxas and our potentially game-changing vaccination technology was announced the winner of the 2024 Accenture Australia Award for Product Innovation ...
Fresh funds for Qld needle-free vaccine tech start-up Vaxxas
Webb23 mars 2024 · Vaxxas announced today that it was granted an exclusive license for a next-generation COVID-19 vaccine to be used with its delivery patch. Cambridge, Massachusetts-based Vaxxas received the license from The University of Texas at Austin for its HexaPro SARS-CoV-2 spike subunit vaccine. Webb16 okt. 2024 · 无针 疫苗开发有了新的进展 。 日前,昆士兰生物技术初创公司Vaxxas 与生物制药公司Merck和包装设备生产制造公司HarroHöfliger确定合作,加速将其HD-MAP技术临床试验和生产等商业化进程。 无针疫苗的临床试验和生产,得以进一步加速 。. Vaxxas是 UniQuest的衍生公司,其先进的平台可通过在皮肤上贴上 ... granard motte and bailey
Bill Gates backs Aussie patch-up for next pandemic
Webb10 feb. 2024 · CAMBRIDGE, Mass. & BRISBANE, Australia, February 10, 2024--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the initiation of a Phase I ... Webb9 okt. 2024 · Vaxxas completes venture financing Vaxxas Pty. Ltd. , Brisbane, Australia Business: Drug delivery, Infectious Date completed: 8/1/11 Type: Venture financing … WebbVaxxas 3,787 followers on LinkedIn. RETHINKING WHAT'S POSSIBLE WITH VACCINES Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will help the world in rethinking what's possible with vaccines. granard national school